ACSL5 Antikörper (AA 33-683) (HRP)
Kurzübersicht für ACSL5 Antikörper (AA 33-683) (HRP) (ABIN7158517)
Target
Alle ACSL5 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 33-683
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Long-chain-fatty-acid--CoA ligase 5 protein (33-683AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- ACSL5 (Acyl-CoA Synthetase Long-Chain Family Member 5 (ACSL5))
-
Andere Bezeichnung
- ACSL5
-
Hintergrund
-
Background: Acyl-CoA synthetases (ACSL) activate long-chain fatty acids for both synthesis of cellular lipids, and degradation via beta-oxidation. ACSL5 may activate fatty acids from exogenous sources for the synthesis of triacylglycerol destined for intracellular storage. Utilizes a wide range of saturated fatty acids with a preference for C16-C18 unsaturated fatty acids. It was suggested that it may also stimulate fatty acid oxidation. At the villus tip of the crypt-villus axis of the small intestine may sensitize epithelial cells to apoptosis specifically triggered by the death ligand TRAIL. May have a role in the survival of glioma cells.
Aliases: ACSL5 antibody, ACS5 antibody, FACL5 antibody, UNQ633/PRO1250 antibody, Long-chain-fatty-acid--CoA ligase 5 antibody, EC 6.2.1.3 antibody, Arachidonate--CoA ligase antibody, EC 6.2.1.15 antibody, Long-chain acyl-CoA synthetase 5 antibody, LACS 5 antibody
-
UniProt
- Q9ULC5
Target
-